人心周细胞与内源性心脏祖细胞共表达从发育到疾病状态的变化
该研究利用胎儿和成人心脏标本,通过免疫组化、细胞分离培养与分化实验,探讨心周细胞与c-kit+心脏祖细胞的空间关系。发现c-kit+细胞频率及其与周细胞的共表达随心脏发育而下降,而缺血后心房血管壁中c-kit表达增加且与内皮、周细胞标志物共定位,提示心脏干细胞龛在缺血后被重新激活。
要点
- 胎儿心脏周细胞与c-kit+细胞表达早期心脏转录因子Nkx2.5和Islet1,具转分化潜能。
- c-kit+细胞频率及与周细胞共表达随心脏发育下降,妊娠19周已明显。
- 缺血后心房<50μm血管c-kit表达增加,c-kit与内皮、周细胞标志物共定位。
核心结论
- 胎儿心脏周细胞和c-kit+细胞表达早期心脏转录因子并具有转分化潜能,该潜能随发育至成人而下降。
- 缺血后心房血管壁内的心脏干细胞龛活动被重新激活。
研究设计与样本
- 使用经伦理批准获取的胎儿和成人人类心脏标本进行免疫组化、细胞分离、培养与分化实验。
- 对CD146+胎儿周细胞和c-kit+细胞进行单染和双染的多系分化评估,并用qPCR定量CD31基因表达。
主要发现
- c-kit+细胞频率及其与周细胞的共表达随心脏发育下降,妊娠第19周已明显。
- 周细胞和c-kit+细胞表达Nkx2.5和Islet1,仅c-kit+细胞表达SSEA3(24%)。
- 心脏周细胞和c-kit+细胞不形成CD31+网络,与两种培养细胞均无CD31染色相关。
- 健康成人心脏中CD146局限于血管结构,缺血后也出现于血管外。
- 缺血导致c-kit表达增加,尤其在直径<50μm的血管中,且c-kit、内皮和周细胞标志物共定位于同一心房细胞。
关键数值与推荐
- c-kit+细胞中SSEA3表达率为24%。
- 直径>50μm的血管主要仅显示内皮标志物vWF和周细胞标志物CD146染色,未检测到c-kit共表达。
临床怎么用
- 理解心周细胞与c-kit+细胞在发育和缺血中的动态变化,可能为冠状动脉疾病提供新的治疗策略思路。
- 关注心房血管壁干细胞龛在缺血后的再激活现象,作为潜在治疗靶点研究方向。
局限性
- 左心室急性缺血因心肌破坏影响损伤区心脏干细胞标志物的检测。
- 右、左心耳缺血区域vWF与CD146共定位水平低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Focussing on the potential role of cardiovascular cell therapy, we investigated the spatial relationship between pericytes (cells with cardiac repair capabilities that ensheath blood vessels) and endogenous cardiac progenitors within stem cells' niches. We explored possible changes in their co-localisation in developing human hearts from foetal to adult stage and following ischaemia. METHODS: Foetal and adult human heart specimens, obtained under ethical consent (University of Edinburgh ethics committee), were used for immunohistochemistry, cell isolation, culture and differentiation. Multi-lineage differentiation in culture, by single and double staining was completed for CD 146+ foetal pericytes and c-kit+ cells. Endothelial markers (CD31) gene expression was quantified by qPCR. RESULTS: c-kit+ cells frequency and coexpression with pericytes decrease with heart development, already evident by gestation week 19th. Pericytes and c-kit+ cells express the early cardiac transcription factors Nkx2.5 and Islet 1. Only c-kit+ cells express the stemness marker SSEA3 (24%), known to progressively decrease with cell differentiation. Endothelial differentiation assessment shows that cardiac pericytes and c-kit+ cells do not form CD31+ networks. This finding correlates with absence of staining for CD31 marker in both cultured cells' types. The cardiac marker α-actin was present in both cell populations. In healthy adult heart, pericyte markers CD146 localise within the vasculature. Following ischaemia this pericyte marker becomes also evident outside the vasculature.In healthy adult atrium, c-kit expression is low and coexpression with other markers inconspicuous. Ischaemia leads to increased c-kit expression, particularly in blood vessels <50um diameter. Furthermore, following ischaemia c-kit, endothelium and pericyte markers co-localise within the same atrial cells. Blood vessels >50μm diameter showed mostly only staining for endothelial (vWF) and pericyte (CD146) markers, with no co-expression of c-kit marker identified. Staining patterns within the ischaemic regions of the right and left atrial appendages revealed low levels of colocalisation between vWF and CD146. Acute ischaemia of the left ventricle affected the detection of cardiac stem cells markers in the area of injury, due to myocardium disruption. CONCLUSION: Foetal heart pericytes and c-kit+ cells express early cardiac transcription factors and show trans-differentiation potential, which decreases in healthy adult hearts. The preservation and activity of cardiac stem cells niches within the atrium vasculature appears re-activated in post-ischaemic hearts. Better understanding of cardiac c-kit+ and pericyte cells during-human embryonic development and during ischaemia may identify alternative novel therapeutic strategy against coronary artery disease.
引用
- Lerman DA, Diaz M, Peault B, et al. Changes in coexpression of pericytes and endogenous cardiac progenitor cells from heart development to disease state. Eur Heart J. 2018. PMID: 30270958. doi:10.1093/eurheartj/ehy565.P1850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。